An artificial intelligence-based endoscopic scoring system may better reflect symptoms and quality of life in ulcerative ...

A study published in iMetaMed reveals that the mTOR inhibitor Everolimus treats ulcerative colitis through a two-pronged approach: inhibiting the CLEC4E inflammatory pathway in macrophages and ...

Streamlined pharmacologic recommendations challenge the stepwise approach for moderately to severely active disease.

Many teas offer anti-inflammatory health benefits and some may have gut health benefits, too. Ginger tea, peppermint tea, ...

A review of literature published over the last 5 years on ustekinumab in Crohn disease (CD) summarized 42 clinical studies on the efficacy and safety of ustekinumab products, including biosimilars, ...

A team led by scientists at King's College London, in collaboration with national and international partners, has discovered ...

Crohn disease is a chronic inflammatory bowel disease that requires long-term medical and surgical management to improve quality of life.

Tyruko (natalizumab-sztn), a biosimilar to Tysabri (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics.